Drug research alliance targets diseases of developing world

05/3/2005 | Los Angeles Times (tiered subscription model)

An alliance of drugmakers, philanthropists and governments are targeting neglected diseases such as malaria and tuberculosis that infect millions of people every year in low-income countries with little ability to pay for treatments. In addition to GlaxoSmithKline's Drugs for the Developing World center, AstraZeneca, Novartis and other drugmakers have joined several such alliances.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care